Farms.com Home   News

Canola Futures Feeling the Energy

Tight Canadian supplies have helped lift canola futures to near the top of a three-month trading range but more recent strength – and future market direction – may be more closely tied to the energy complex.

"There seems to be a mindset shift occurring here, and its making canola become a pure energy play," said analyst Mike Jubinville of MarketsFarm.

With crude oil, natural gas, and other energy markets seeing strength around the world, Jubinville said canola appears to be getting caught up in the updraft. As long as the bullish momentum is being maintained in the energy sector, it's hard to envision canola falling back in any sustained fashion, he added.

Rapeseed grown in Europe is a major feedstock for biodiesel production there, with rapeseed futures trading at record high levels. Jubinville expected activity in European rapeseed would be a key feature to watch in the Canadian canola market.

"(But) if we have a change in momentum in the energy sector, that will extinguish this current rally," he added.

Click here to see more...

Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.